BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27539965)

  • 21. SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma.
    Hsiao SC; Cortada IR; Colomo L; Ye H; Liu H; Kuo SY; Lin SH; Chang ST; Kuo TU; Campo E; Chuang SS
    Histopathology; 2012 Oct; 61(4):685-93. PubMed ID: 22642745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features.
    Parrens M; Belaud-Rotureau MA; Fitoussi O; Carerre N; Bouabdallah K; Marit G; Dubus P; de Mascarel A; Merlio JP
    Histopathology; 2006 Mar; 48(4):353-62. PubMed ID: 16487357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin D1 as an aid in the diagnosis of mantle cell lymphoma in skin biopsies: a case report.
    Moody BR; Bartlett NL; George DW; Price CR; Breer WA; Rothschild Y; Kraus MD
    Am J Dermatopathol; 2001 Oct; 23(5):470-6. PubMed ID: 11801782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.
    Klener P; Fronkova E; Berkova A; Jaksa R; Lhotska H; Forsterova K; Soukup J; Kulvait V; Vargova J; Fiser K; Prukova D; Alam M; Calvin Lenyeletse Maswabi B; Michalova K; Zemanova Z; Jancuskova T; Pekova S; Trneny M
    Int J Cancer; 2016 Nov; 139(10):2252-60. PubMed ID: 27407063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BCL-1 (PRAD-1/cyclin D-1) overexpression distinguishes the blastoid variant of mantle cell lymphoma from B-lineage lymphoblastic lymphoma.
    Soslow RA; Zukerberg LR; Harris NL; Warnke RA
    Mod Pathol; 1997 Aug; 10(8):810-7. PubMed ID: 9267824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin manifestation of mantle cell lymphoma.
    Motegi S; Okada E; Nagai Y; Tamura A; Ishikawa O
    Eur J Dermatol; 2006; 16(4):435-8. PubMed ID: 16935806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome.
    Michaux L; Wlodarska I; Theate I; Stul M; Scheiff JM; Deneys V; Ferrant A; Hagemeijer A
    Ann Hematol; 2004 Sep; 83(9):578-83. PubMed ID: 15138714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mantle cell lymphoma presenting with unusual morphology in an adolescent female: a case report and review of the literature.
    Smock KJ; Yaish HM; Cairo MS; Lones MA; Willmore-Payne C; Perkins SL
    Pediatr Dev Pathol; 2007; 10(5):403-8. PubMed ID: 17929987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas.
    Belaud-Rotureau MA; Parrens M; Dubus P; Garroste JC; de Mascarel A; Merlio JP
    Mod Pathol; 2002 May; 15(5):517-25. PubMed ID: 12011256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
    Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
    Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In situ hybridization and reverse transcription-polymerase chain reaction for cyclin D1 mRNA in the diagnosis of mantle cell lymphoma in paraffin-embedded tissues.
    Athanasiou E; Kotoula V; Hytiroglou P; Kouidou S; Kaloutsi V; Papadimitriou CS
    Mod Pathol; 2001 Feb; 14(2):62-71. PubMed ID: 11235907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary cutaneous mantle cell lymphoma with blastic features: report of a rare case with special reference to staging and effectiveness of chemotherapy.
    Lynch DW; Verma R; Larson E; Geis MC; Jassim AD
    J Cutan Pathol; 2012 Apr; 39(4):449-53. PubMed ID: 22121909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Detection of cyclin D1 protein expression and t(11;14) chromosomal translocation in paraffin-embedded tissues and its clinicopathologic significance for mantle cell lymphoma].
    Shui RH; Yang WT; Sun MH; Shi DR; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2003 Aug; 32(4):337-41. PubMed ID: 14514379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary cutaneous mantle cell lymphoma of the leg with blastoid morphology and aberrant immunophenotype: a diagnostic challenge.
    Cesinaro AM; Bettelli S; Maccio L; Milani M
    Am J Dermatopathol; 2014 Feb; 36(2):e16-8. PubMed ID: 23612032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia.
    Ruchlemer R; Parry-Jones N; Brito-Babapulle V; Attolico I; Wotherspoon AC; Matutes E; Catovsky D
    Br J Haematol; 2004 May; 125(3):330-6. PubMed ID: 15086413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MYC overexpression correlates with MYC amplification or translocation, and is associated with poor prognosis in mantle cell lymphoma.
    Choe JY; Yun JY; Na HY; Huh J; Shin SJ; Kim HJ; Paik JH; Kim YA; Nam SJ; Jeon YK; Park G; Kim JE
    Histopathology; 2016 Feb; 68(3):442-9. PubMed ID: 26100211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.
    Chuang SS; Huang WT; Hsieh PP; Tseng HH; Campo E; Colomer D; Ye H; Lu CL; Chang HM; Cho CY; Huang SH; Lu YC; Wu JD
    Pathol Int; 2006 Aug; 56(8):440-8. PubMed ID: 16872438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
    Pott C; Schrader C; Brüggemann M; Ritgen M; Harder L; Raff T; Tiemann M; Dreger P; Kneba M
    Eur J Haematol; 2005 Apr; 74(4):353-8. PubMed ID: 15777349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases.
    Coffin CM; Hornick JL; Fletcher CD
    Am J Surg Pathol; 2007 Apr; 31(4):509-20. PubMed ID: 17414097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.